Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with ...

The Champions Trophy Group B fixture between Australia and South Africa in Rawalpindi has been abandoned without a ball being bowled after persistent rain kept the players from the field.

Compounders have been permitted to manufacture copycat versions of Novo’s semaglutide and Lilly’s tirzepatide since 2022 when the FDA declared that both were in shortage. In October ...

This legal move, initiated by the Outsourcing Facilities Association and others in a Fort Worth, Texas federal court, argues that the FDA's ruling, which states no existing shortage of the active ...

Whether you’ve just started taking semaglutide for weight loss or are considering other GLP-1 medications, you likely have many questions. These include the optimal dose, when to slow down or ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick ...

Makers of copycat versions of Novo Nordisk's (NVO) popular weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing the FDA for removing the GLP-1 medication from its shortage list.

Direct-to-consumer telehealth company Hims & Hers is forging ahead in the aftermath of the semaglutide shortage ending last week. Hims & Hers faces new headwinds in its weight management segment ...

Semaglutide supports weight loss in MASLD/MASH for all diabetes groups The medication shows consistent effectiveness across groups, with no major differences in weight loss By reducing weight and ...

NAION causes sudden vision loss in one eye due to damaged optic nerves MONDAY, Feb. 24, 2025 (HealthDay News) -- People taking the weight-loss drug semaglutide could be at a slightly increased risk ...